| Followers | 145 |
| Posts | 27554 |
| Boards Moderated | 3 |
| Alias Born | 02/07/2004 |
Thursday, September 14, 2017 9:03:09 AM
Sep. 14, 2017 8:48 AM ET|By: Mamta Mayani, SA News Editor
BiondVax Pharmaceuticals (NASDAQ:BVXV) prices an underwritten public offering of 1.5M ADSs, each ADS representing 40 of its ordinary shares at a price of $6.00 per ADS.
Underwriters over-allotment is an additional 166,667 ADSs.
Closing date is September 18.
Shares are down 16% premarket on robust volume. Yesterday's close was $7.63.
____________________________________________
Grrrrrrr
Recent BVXV News
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM
